Health Services · Medical/Nursing Services · NSE: INVICTA · data 2026-10-09

Invicta Diagnostic limited

Health check: Weak (1.8/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹66

Market cap

—

P/E

—

P/B

—

ROE

—

ROCE

—

Debt / equity

—

Dividend yield

—

1-year return

-22.4%

52-week high

₹105

52-week low

₹58.1

Operating margin

—

Growth

Revenue (last 12 months)	—
Net profit (last 12 months)	—
Sales growth, 3 years (yearly)	—
Profit growth, 3 years (yearly)	—

Similar companies

Rays of Belief Limited (MOMSBELIEF) · Pramodini Medicare Limited (PRAMODINI) · Lotus Eye Hospital And Institute Ltd (LOTUSEYE) · Vaidya Sane Ayurved Laboratories Limited (MADHAVBAUG) · Nidan Laboratories and Healthcare Limited (NIDAN)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open INVICTA in NSE Scanner →